Cellid, Statistics

Total Valuation

Cellid, has a market cap or net worth of KRW 76.08 billion. The enterprise value is 80.18 billion.

Market Cap	76.08B
Enterprise Value	80.18B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Cellid, has 21.10 million shares outstanding. The number of shares has increased by 53.18% in one year.

Current Share Class	n/a
Shares Outstanding	21.10M
Shares Change (YoY)	+53.18%
Shares Change (QoQ)	+20.27%
Owned by Insiders (%)	15.56%
Owned by Institutions (%)	0.00%
Float	17.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.28
PB Ratio	1.49
P/TBV Ratio	1.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.54
EV / Sales	19.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.94

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.26.

Current Ratio	2.32
Quick Ratio	1.89
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-25.38

Financial Efficiency

Return on equity (ROE) is -26.74% and return on invested capital (ROIC) is -12.81%.

Return on Equity (ROE)	-26.74%
Return on Assets (ROA)	-10.70%
Return on Invested Capital (ROIC)	-12.81%
Return on Capital Employed (ROCE)	-16.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.17% in the last 52 weeks. The beta is 1.36, so Cellid,'s price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-3.17%
50-Day Moving Average	4,484.20
200-Day Moving Average	4,990.95
Relative Strength Index (RSI)	38.15
Average Volume (20 Days)	315,903

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellid, had revenue of KRW 4.17 billion and -12.26 billion in losses. Loss per share was -743.00.

Revenue	4.17B
Gross Profit	697.69M
Operating Income	-11.98B
Pretax Income	-12.26B
Net Income	-12.26B
EBITDA	-9.25B
EBIT	-11.98B
Loss Per Share	-743.00

Full Income Statement

Balance Sheet

The company has 9.07 billion in cash and 13.17 billion in debt, giving a net cash position of -4.10 billion or -194.42 per share.

Cash & Cash Equivalents	9.07B
Total Debt	13.17B
Net Cash	-4.10B
Net Cash Per Share	-194.42
Equity (Book Value)	51.20B
Book Value Per Share	2,419.24
Working Capital	6.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.32 billion and capital expenditures -5.91 billion, giving a free cash flow of -16.22 billion.

Operating Cash Flow	-10.32B
Capital Expenditures	-5.91B
Free Cash Flow	-16.22B
FCF Per Share	-768.78

Full Cash Flow Statement

Margins

Gross margin is 16.75%, with operating and profit margins of -287.64% and -294.33%.

Gross Margin	16.75%
Operating Margin	-287.64%
Pretax Margin	-294.33%
Profit Margin	-294.33%
EBITDA Margin	-222.01%
EBIT Margin	-287.64%
FCF Margin	n/a

Dividends & Yields

Cellid, does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.18%
Shareholder Yield	-53.18%
Earnings Yield	-16.11%
FCF Yield	-21.33%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellid, has an Altman Z-Score of 0.31. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.31
Piotroski F-Score	n/a